Search results
- 971.88Add to watchlist+1.97 (+0.20%)As of Fri. May 31, 2024 12:26 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open969.14High979.98Low967.43
- Mkt Cap107.09BP/E (TTM)28.71Div & YieldN/A & N/A
- Prev. Close969.9152 Wk. Low684.8152 Wk. High998.33
What analysts are sayingRelated stocks
NasdaqGS - Nasdaq Real Time Price•USD. Regeneron Pharmaceuticals, Inc. (REGN) Follow. 969.91+3.42(+0.35%) At close: May 30 at 4:00 PM EDT. 972.27+2.36(+0.24%) After hours: May 30 at 6:36 PM...
- Historical Data
Discover historical prices for REGN stock on Yahoo Finance....
- Chart
Interactive Chart for Regeneron Pharmaceuticals, Inc....
- Analysis
See Regeneron Pharmaceuticals, Inc. (REGN) stock analyst...
- Options
View the basic REGN option chain and compare options of...
- Profile
See the company profile for Regeneron Pharmaceuticals, Inc....
- Press Releases
Regeneron Announces Investor Conference Presentations....
- Historical Data
May 24, 2024 · Novonesis A/S Series B. -0.21%. kr.197.04B. REGN | Complete Regeneron Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial...
People also ask
What is the stock price of Regeneron Pharmaceuticals?
Does Regeneron Pharmaceuticals Inc (regn) pay a dividend?
Who founded Regeneron Pharmaceuticals Inc?
When is Regeneron Pharmaceuticals' next quarterly earnings announcement?
Get the latest Regeneron Pharmaceuticals Inc (REGN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
Discover real-time Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead...
Regeneron Pharmaceuticals, Inc.'s stock symbol is REGN and currently trades under NASDAQ. It’s current price per share is approximately $966.49.
- Vertex Pharmaceuticals Incorporated
- Biotechnology
- 5,400
- 101.91B
2 days ago · Regeneron's stock dips after earnings fall short of estimates. Regeneron Pharmaceuticals Inc.'s stock REGN, +1.44% fell 3% early Thursday, after the company's first-quarter earnings fell short of estimates. The company had net income of $722 million, or $6.27 a s... 26 days ago - Market Watch.
View the latest Regeneron Pharmaceuticals Inc. (REGN) stock price, news, historical charts, analyst ratings and financial information from WSJ.